-
Posted by
Two Blokes April 24, 2025 -
Filed in
Stock
-
10 views
France's Sanofi reported first-quarter profit that beat analysts' expectations on Thursday, boosted by strong demand for its anti-inflammatory drug Dupixent, as well as newer treatments and vaccines.
